We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
Cap. Flow
-$1.66B
Cap. Flow %
-13.11%
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEI icon
401
Methode Electronics
MEI
$585M
$7.28M 0.06%
196,578
+6,235
+3% +$269K
ICE icon
402
Intercontinental Exchange
ICE
$84.1B
$7.28M 0.06%
77,389
-16,117
-17% -$1.72M
SBAC icon
403
SBA Communications
SBAC
$19.4B
$7.27M 0.06%
22,709
+10,391
+84% +$3.5M
MCHP icon
404
Microchip Technology
MCHP
$40.4B
$7.26M 0.06%
124,941
-37,784
-23% -$2.5M
AEM icon
405
Agnico Eagle Mines
AEM
$85B
$7.24M 0.06%
158,314
+13,732
+9% +$764K
IDXX icon
406
Idexx Laboratories
IDXX
$46.5B
$7.22M 0.06%
20,594
-2,759
-12% -$1.13M
AME icon
407
Ametek
AME
$57.6B
$7.19M 0.06%
65,401
+3,146
+5% +$382K
HEES
408
DELISTED
H&E Equipment Services
HEES
$7.18M 0.06%
247,730
+180
+0.1% +$6.32K
MCO icon
409
Moody's
MCO
$81.9B
$7.16M 0.06%
26,337
+371
+1% +$111K
EBAY icon
410
eBay
EBAY
$48.9B
$7.13M 0.06%
171,155
-83,340
-33% -$4.06M
CTRA
411
DELISTED
Coterra Energy
CTRA
$7.12M 0.06%
275,896
-2,505
-0.9% -$76K
ABT icon
412
Abbott
ABT
$187B
$7.06M 0.06%
64,980
-72,040
-53% -$8.18M
INCY icon
413
Incyte
INCY
$24B
$7.04M 0.06%
92,685
-39,031
-30% -$2.96M
CME icon
414
CME Group
CME
$95B
$7.03M 0.06%
34,328
-7,877
-19% -$1.67M
CENTA icon
415
Central Garden & Pet Co Class A
CENTA
$2.54B
$7M 0.06%
218,659
-121
-0.1% -$3.99K
CAG icon
416
Conagra Brands
CAG
$7.11B
$6.99M 0.06%
204,244
+9,397
+5% +$320K
SJI
417
DELISTED
South Jersey Industries, Inc.
SJI
$6.94M 0.05%
203,248
+3,397
+2% +$116K
DTE icon
418
DTE Energy
DTE
$29.1B
$6.93M 0.05%
54,677
-28,095
-34% -$3.66M
BEN icon
419
Franklin Resources
BEN
$17.3B
$6.91M 0.05%
296,381
+47,014
+19% +$1.2M
UTHR icon
420
United Therapeutics
UTHR
$22.6B
$6.88M 0.05%
29,208
-7,237
-20% -$1.47M
EFT
421
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$6.88M 0.05%
584,028
+67,765
+13% +$844K
HZNP
422
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.88M 0.05%
86,192
+13,602
+19% +$1.29M
AXS icon
423
AXIS Capital
AXS
$7.62B
$6.87M 0.05%
120,402
+835
+0.7% +$47.6K
DLTR icon
424
Dollar Tree
DLTR
$24.9B
$6.86M 0.05%
44,041
-9,409
-18% -$1.49M
BYM
425
DELISTED
BlackRock Municipal Income Quality Trust
BYM
$6.85M 0.05%
552,820
-16,610
-3% -$205K

Similar funds

Guggenheim Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.

  • Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
  • Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
  • Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
  • Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
  • Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
  • Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
  • Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.